Sign in Subscribe
BioMed

🧬 BioMed Pulse · 2026-07-24 02:02 UTC

BIOMED PULSE

July 24, 2026 - Daily Briefing on Longevity, Viruses & New Cures

⚡ TL;DR

The Ebola Bundibugyo virus disease outbreak in DRC and Uganda has surpassed 2,124 confirmed cases and 828 deaths as of July 15 - the largest filovirus emergency in years and a declared PHEIC. The overall mood is tense: multiple concurrent outbreaks (Ebola, hantavirus, Cyclospora, West Nile) are running simultaneously, while longevity science signals that up to 45% of dementia cases may be preventable.

🦠 OUTBREAKS & VIRUSES

EBOLA BUNDIBUGYO VIRUS DISEASE - DRC AND UGANDA (ACTIVE PHEIC)

  • As of July 15, 2026, a cumulative 2,124 confirmed cases and 828 deaths have been reported from the DRC, with cross-border transmission continuing in Uganda. [1]
  • WHO declared the event a Public Health Emergency of International Concern (PHEIC) on May 22, 2026; it does not yet meet criteria for a pandemic emergency per the IHR Emergency Committee. [2]
  • Africa CDC and WHO launched a joint continental Ebola response plan on June 5 aimed at raising US$518 million to support African countries. [3]
  • WHO published its first comprehensive filovirus clinical management guidelines on June 17, covering all Ebola and Marburg virus types, in direct response to the outbreak. [4]
  • The PARTNERS clinical trial opened patient enrolment on July 2 in DRC to evaluate the first effective treatments specifically for Bundibugyo virus disease. [5]
  • WHO added the first molecular diagnostic test for Bundibugyo virus (BDBV) to its Emergency Use Listing on July 2, enabling rapid genetic detection in blood samples. [6]
  • CDC mobilized an international response beginning May 17, activated enhanced airport screening at Washington-Dulles on May 21, and expanded screening to Atlanta on May 23. [7] [8] [9]
  • CDC issued a statement on July 10 confirming the outbreak remains active with ongoing CDC support to DRC and Ugandan authorities. [10]

ANDES HANTAVIRUS - M/V HONDIUS CRUISE SHIP (MULTI-COUNTRY)

  • The fifth WHO Disease Outbreak News report (July 2) on the Andes hantavirus (ANDV) outbreak linked to M/V Hondius confirms additional confirmed cases since the prior update of May 13.
  • The original cluster was notified to WHO on May 2, 2026, aboard a 147-passenger cruise ship; seven cases including two lab-confirmed were reported by May 4.
  • CDC provided its own hantavirus response updates through June 24, noting extremely low risk to the general American public.

CYCLOSPORIASIS - TACO BELL / SHREDDED ICEBERG LETTUCE

  • CDC identified shredded iceberg lettuce served at Taco Bell locations in five states as the source of a Cyclospora outbreak affecting 1,644 people as of July 17, 2026.
  • CDC held a Cyclosporiasis response briefing on July 14, 2026, and consumers in affected states were warned to avoid the product.

WEST NILE VIRUS - UNITED STATES

  • CDC reported an early and record-pace West Nile virus season as of July 1, urging mosquito bite prevention over the July 4th holiday weekend across the country.

E. COLI - FROZEN BLUEBERRIES

  • CDC warned on July 7, 2026 of an E. coli outbreak linked to frozen blueberries, with a consumer recall in effect; people are advised not to eat recalled product.

NIPAH VIRUS - INDIA (KERALA)

  • On June 11, 2026, the Kerala State Health Department confirmed one lab-confirmed Nipah virus (NiV) case in an adult male in Kozhikode district who developed neurological symptoms on May 30.
  • A separate NiV case was also confirmed in Bangladesh's Rajshahi Division in February 2026, notified to WHO on February 3.

YELLOW FEVER - GLOBAL

  • From January 1 to May 26, 2026, six countries reported 79 human yellow fever infections; transmission in the Americas that surged in 2025 carried into 2026.

AVIAN INFLUENZA A(H9N2) - ITALY

  • Italy notified WHO of a human H9N2 case in March 2026 in an adult male returning from Senegal; next-generation sequencing confirmed influenza A(H9N2).

MEASLES - BANGLADESH

  • Bangladesh notified WHO on April 4, 2026 of a nationwide measles surge affecting 58 of 64 districts, with 19,161 suspected cases and 2,897 laboratory confirmed across all eight divisions.

MPOX - RECOMBINANT STRAIN (GLOBAL)

  • WHO reported in February 2026 two cases of a recombinant monkeypox virus (MPXV) strain combining genomic elements of clade Ib and clade IIb, a naturally occurring but newly documented event.

NEW WORLD SCREWWORM - UNITED STATES

  • CDC activated its Emergency Operations Center for a New World Screwworm response on June 12, 2026, marking a significant vector/parasite alert for domestic animals and potentially humans.

🧬 LONGEVITY & AGING

DEMENTIA PREVENTION - WHO UPDATED GUIDELINES

  • WHO released updated guidelines on July 15, 2026 concluding that up to 45% of dementia risk could be prevented or delayed through evidence-based interventions across the life course.
  • The guidelines provide countries with specific recommendations targeting modifiable risk factors including physical inactivity, social isolation, hypertension, smoking, and hearing loss.

DELIRIUM AS A BRIDGE FROM INFECTION TO DEMENTIA

  • A Lancet Healthy Longevity commentary (Sipilä and Kivimäki) proposes delirium as the mechanistic missing link between severe infection episodes and subsequent development of dementia.
  • A second corresponding commentary (Penfold, Jiwaji, MacLullich) in the same journal reinforces the clinical importance of detecting and managing delirium to potentially interrupt the dementia pathway.

DEMENTIA PREVENTION - REAL-WORLD READINESS

  • Beeri and Gu writing in Lancet Healthy Longevity argue that translating dementia prevention into practice requires accounting for real-world health inequities and diverse population contexts.

NAD-PLUS RESTORATION FOR AGED BONE REPAIR

  • A study published in Bioactive Materials (Jiang et al., June 27) describes a senescent-metabolism-modulating hierarchical scaffold that restores NAD-plus homeostasis and redox balance specifically to enable bone repair in aged tissue.
  • The mechanism targets cellular senescence directly, repositioning NAD-plus replenishment as a tissue-engineering strategy rather than only a systemic supplement approach.

KAEMPFEROL FROM MORINGA OLEIFERA AND LONGEVITY

  • Research published in Toxicology Reports (Iorjiim et al.) found that kaempferol isolated from Moringa oleifera L. increased longevity and reversed efavirenz-induced functional senescence in Drosophila melanogaster.
  • The finding is notable context given ongoing CDC Salmonella outbreaks linked to moringa leaf powder supplements.

COLLAGEN XVII AND EPIDERMAL STEM CELL PHOTOAGING

  • Wang et al. (Annals of Medicine, July 16) found recombinant human collagen XVII protects epidermal stem cells from blue light-induced photoaging by downregulating the Notch signaling pathway.

HYPERTENSION AND FRAILTY IN AGING POPULATIONS

  • A letter in Blood Pressure journal (Goyal, Kalra, Nagpal, July 7) addresses associations between hypertension and frailty in middle-aged and older adults, drawing on India's Longitudinal Ageing Study data.

HIGH-DOSE INFLUENZA VACCINE IN OLDER ADULTS

  • A systematic review and meta-analysis published in Lancet Healthy Longevity (Zhao et al.) evaluates the effect of high-dose versus standard-dose influenza vaccines on hospitalisation outcomes and mortality in older adults.
  • A linked commentary (Icardi and Paolozzi) discusses benefits and remaining evidence gaps for high-dose flu vaccination strategies in elderly populations.

AMYLOID PET IMAGING IN AGING COHORT

  • A ClinicalTrials.gov study (NCT07099053) is using amyloid PET imaging within the Baltimore Longitudinal Study of Aging to track amyloid protein accumulation in older adults experiencing cognitive decline.

CANCER CASES PROJECTED TO NEARLY DOUBLE BY 2050

  • WHO reported on July 8, 2026 that with currently 20.6 million new cancer cases and close to 10 million deaths annually, new cases are projected to nearly double by 2050 without urgent action.

TAU AND NUCLEAR MECHANOTRANSDUCTION IN NEURONS

  • Sohn et al. (Nucleus, July 7) found that the mechanically-sensitive nuclear envelope protein emerin links nuclear mechanotransduction to tau-induced cytoskeletal remodeling in neurons, a finding relevant to Alzheimer's disease pathology.

P16-INK4A SENESCENCE BIOMARKER VALIDATION

  • Pipella and Thompson (Islets, July 21) published an antibody validation study for detecting the canonical cellular senescence marker p16-INK4A by immunohistochemistry in pancreas tissue, addressing a key reproducibility gap in senescence research.

BURITI SUPPLEMENT TRIAL IN OLDER ADULTS

  • A new ClinicalTrials.gov study (NCT07716839) is evaluating the effects of a buriti palm fruit supplement on body composition and physical function in older adults, with Tai Chi Chuan as a co-intervention.

💊 NEW CURES & APPROVALS

OGSIVEO (NIROGACESTAT HYDROBROMIDE) - SPRINGWORKS THERAPEUTICS

  • openFDA records a supplemental approval action for Ogsiveo (nirogacestat hydrobromide), sponsored by SpringWorks Therapeutics, a gamma-secretase inhibitor approved for desmoid tumors.

SITAGLIPTIN PHOSPHATE GENERIC - DR. REDDY'S LABORATORIES

  • openFDA records an original tentative approval (ORIG TA) for a sitagliptin phosphate generic formulation submitted by Dr. Reddy's Laboratories Ltd (ANDA214700), a DPP-4 inhibitor used in type 2 diabetes management.

GEMCITABINE HYDROCHLORIDE GENERIC - ACTAVIS INC

  • openFDA records a supplemental approval for gemcitabine hydrochloride (ANDA204549), sponsored by Actavis Inc., used in multiple cancers including pancreatic and non-small-cell lung cancer.

NOTE: openFDA entries listed above carry "Invalid Date" timestamps; they reflect activity in the Drugs@FDA database but precise approval dates were not available in this data feed. This is informational, not medical advice.

🧪 CLINICAL TRIALS

B7-H3 CAR-T CELLS IN EXTENSIVE-STAGE SMALL CELL LUNG CANCER

  • A new ClinicalTrials.gov study (NCT07509034, registered July 23, 2026) is evaluating autologous B7-H3-targeting chimeric antigen receptor T cells in previously treated extensive-stage small cell lung cancer and extrapulmonary neuroendocrine cancer.
  • B7-H3 is a protein overexpressed on SCLC and EPNEC tumor cells; the trial uses personalized immune cell engineering to attack these targets.

ASP2138 (CLDN18.2-TARGETING BISPECIFIC) WITH CHEMOTHERAPY AND PEMBROLIZUMAB IN GASTRIC CANCER

  • NCT07673887 (registered July 23, 2026) is studying ASP2138, a bispecific antibody binding Claudin 18.2 on tumor cells and CD3 on T cells, combined with chemotherapy and pembrolizumab in adults with gastric cancer.

MULTITARGETED ADENOVIRUS VACCINE (TriAdeno) PLUS IL-15 SUPERAGONIST N-803 IN PROSTATE CANCER ACTIVE SURVEILLANCE

  • NCT07574541 (registered July 23, 2026) tests a recombinant Ad5 vaccine targeting PSA, MUC-1, and brachyury antigens combined with the IL-15 superagonist N-803 in men with clinically localized prostate cancer on active surveillance.

AMYLOID PET IN BALTIMORE LONGITUDINAL STUDY OF AGING

  • NCT07099053 is tracking amyloid protein accumulation longitudinally via PET imaging in cognitively normal and declining adults 35 and older in the Baltimore Longitudinal Study of Aging cohort.

GERIATRIC SURGERY VERIFICATION PROGRAM AT JAMES CANCER HOSPITAL

  • NCT07606287 examines implementation of the American College of Surgeons Geriatric Surgery Verification Program for adults age 65 and older undergoing surgery, aiming to reduce age-related surgical complications.

VAS-101 (CURCUMIN BIOAVAILABILITY FORMULATION) IN SICKLE CELL DISEASE

  • NCT07566494 is evaluating escalating doses of VAS-101, a curcumin-based compound designed for improved bioavailability, in patients with stable sickle cell disease to assess red blood cell health improvements.

HOMOCYSTEIC ACID SKIN BIOSTIMULATOR FOR PHOTOAGED SKIN

  • NCT07722351 (registered July 23, 2026) is assessing a chemical biostimulator containing ammonium trichloroacetate, homocysteic acid, phytic acid, and citric acid across four treatment sessions in women with photoaged skin.

18F-FLUCICLOVINE PET/CT IN MULTIPLE MYELOMA

  • NCT06103838 is testing whether the radiotracer 18F-fluciclovine in PET/CT imaging can detect relapsed multiple myeloma earlier than conventional imaging in a disease where median survival is 5-8 years post-diagnosis.

BELINOSTAT PHARMACOKINETICS BY UGT1A1 GENOTYPE IN HIGH-GRADE NEUROENDOCRINE CARCINOMA

  • NCT06406465 uses UGT1A1 genotyping to personalize dosing of belinostat combined with etoposide and cisplatin in high-grade neuroendocrine carcinomas, aiming to reduce toxicity in poorer metabolizers.

📢 PUBLIC HEALTH

CYCLOSPORA OUTBREAK AT TACO BELL - CONSUMER WARNING

  • CDC urges consumers in five affected states to avoid shredded iceberg lettuce served at Taco Bell locations; 1,644 people have been sickened by Cyclospora cayetanensis.

FROZEN BLUEBERRY E. COLI RECALL

  • CDC warns consumers not to eat recalled frozen blueberries linked to an active E. coli outbreak; check freezers and discard recalled product.

GLOBAL HUNGER DECLINES FOR THIRD CONSECUTIVE YEAR

  • The UN State of Food Security and Nutrition 2026 report (released July 21) confirmed global hunger declined for a third consecutive year in 2025, though progress is fragile and insufficient to meet 2030 SDG targets.

GLOBAL CHILDHOOD IMMUNIZATION COVERAGE - 2025 DATA

  • WHO and UNICEF reported that 90% of infants globally (116 million) received at least one DTP dose in 2025, and 85% (110 million) completed all three doses, a modest forward step despite conflict and vaccine hesitancy.

HEALTHCARE-ASSOCIATED INFECTIONS DECLINING IN U.S.

  • CDC data released July 15, 2026 show fewer hospital-acquired infections in 2023, marking continued progress in patient safety.

EL SALVADOR ELIMINATES TRACHOMA

  • WHO validated El Salvador on July 13, 2026 as having eliminated trachoma as a public health problem; trachoma is the world's leading infectious cause of blindness.

UNSAFE FOOD KILLS 1.5 MILLION ANNUALLY - WHO

  • WHO estimates unsafe food causes 866 million illnesses and 1.5 million deaths per year globally, with children under 5 facing nearly three times the illness risk of older populations.

WHO PANDEMIC AGREEMENT - PABS ANNEX NEGOTIATIONS CONTINUE

  • WHO Member States advanced but did not finalize the Pathogen Access and Benefit Sharing (PABS) annex of the WHO Pandemic Agreement as of July 18-20, 2026; further discussions required.

ROAD DEATHS DOWN 21% GLOBALLY SINCE 2011

  • WHO released data on July 20 showing global road traffic deaths declined 21% between 2011 and 2025 despite the addition of more than one billion motor vehicles to the world's roads.

BIOMED PULSE is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider for personal health decisions.

📎 Sources

  1. Ebola disease caused by Bundibugyo virus, Democratic Republic … — WHO Disease Outbreak News
  2. First meeting of the IHR Emergency Committee regarding the epi… — WHO News
  3. Africa CDC and WHO launch joint continental Ebola response plan — WHO News
  4. WHO issues comprehensive guidelines on filovirus disease, incl… — WHO News
  5. Patient enrolment begins in a scientific trial to identify the… — WHO News
  6. WHO adds first diagnostic test for Ebola Bundibugyo virus to i… — WHO News
  7. CDC Mobilizes International Response Following Ebola Disease O… — CDC Newsroom
  8. Enhanced Ebola Airport Screening Begins at Washington-Dulles I… — CDC Newsroom
  9. Enhanced Ebola Airport Screening Expands to Atlanta — CDC Newsroom
  10. CDC Statement on Ebola Outbreak in the Democratic Republic of … — CDC Newsroom

Curated from official sources — WHO/CDC/ECDC/openFDA/ClinicalTrials.gov/Europe PMC. Informational only — not medical advice.
Serial 20260724-02-v37 · 2026-07-24 02:02 UTC · pulse.uzylab.com

Read next